By now, hundreds of apps exist that provide access to health services (via doctor-on-demand or communication platforms), support health professionals in diagnostics and data analytics or help patients manage their symptoms with digital companions.

However, while these apps support existing therapies, they are not focused on tackling disease causes. The next wave of digitalization will develop Software as a Drug solutions that go a step further by providing treatment, thereby offering a better risk-benefit profile over existing treatment options.

Software as a Drug is pure software, which on its own has a relevant physiological effect in a comparable manner to the standard of care. Ababax‘ Digital Drugs are streamed and delivered using commercially available devices, making them highly accessible and adaptable to the patients‘ individual needs.